BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 21705065)

  • 1. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.
    Lind M; Bounias I; Olsson M; Gudbjörnsdottir S; Svensson AM; Rosengren A
    Lancet; 2011 Jul; 378(9786):140-6. PubMed ID: 21705065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.
    Lind M; Olsson M; Rosengren A; Svensson AM; Bounias I; Gudbjörnsdottir S
    Diabetologia; 2012 Nov; 55(11):2946-53. PubMed ID: 22895807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term excess risk of heart failure in people with type 1 diabetes: a prospective case-control study.
    Rosengren A; Vestberg D; Svensson AM; Kosiborod M; Clements M; Rawshani A; Pivodic A; Gudbjörnsdottir S; Lind M
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):876-85. PubMed ID: 26388415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds.
    Zoungas S; Chalmers J; Ninomiya T; Li Q; Cooper ME; Colagiuri S; Fulcher G; de Galan BE; Harrap S; Hamet P; Heller S; MacMahon S; Marre M; Poulter N; Travert F; Patel A; Neal B; Woodward M;
    Diabetologia; 2012 Mar; 55(3):636-43. PubMed ID: 22186981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new model for 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR).
    Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Gudbjörnsdottir S;
    Diabet Med; 2011 Oct; 28(10):1213-20. PubMed ID: 21627687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycated haemoglobin and cardiovascular outcomes in people with Type 2 diabetes: a large prospective cohort study.
    Elley CR; Kenealy T; Robinson E; Drury PL
    Diabet Med; 2008 Nov; 25(11):1295-301. PubMed ID: 19046219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.
    Currie CJ; Peters JR; Tynan A; Evans M; Heine RJ; Bracco OL; Zagar T; Poole CD
    Lancet; 2010 Feb; 375(9713):481-9. PubMed ID: 20110121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes.
    Schulze MB; Shai I; Manson JE; Li T; Rifai N; Jiang R; Hu FB
    Diabetologia; 2004 Dec; 47(12):2129-36. PubMed ID: 15662553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.
    Rawshani A; Rawshani A; Sattar N; Franzén S; McGuire DK; Eliasson B; Svensson AM; Zethelius B; Miftaraj M; Rosengren A; Gudbjörnsdottir S
    Circulation; 2019 Apr; 139(16):1900-1912. PubMed ID: 30798638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk).
    Khaw KT; Wareham N; Luben R; Bingham S; Oakes S; Welch A; Day N
    BMJ; 2001 Jan; 322(7277):15-8. PubMed ID: 11141143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of cardiovascular disease in patients with Type 2 diabetes. 6.3 years of follow-up.
    Rius Riu F; Salinas Vert I; Lucas Martín A; Romero González R; Sanmartí Sala A
    J Diabetes Complications; 2003; 17(5):235-42. PubMed ID: 12954150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
    Stratton IM; Adler AI; Neil HA; Matthews DR; Manley SE; Cull CA; Hadden D; Turner RC; Holman RR
    BMJ; 2000 Aug; 321(7258):405-12. PubMed ID: 10938048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia.
    Khan HA; Sobki SH; Khan SA
    Clin Exp Med; 2007 Mar; 7(1):24-9. PubMed ID: 17380302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study.
    Huppertz E; Pieper L; Klotsche J; Stridde E; Pittrow D; Böhler S; Lehnert H
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):6-14. PubMed ID: 18465681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvements in glycaemic control and cholesterol concentrations associated with the Quality and Outcomes Framework: a regional 2-year audit of diabetes care in the UK.
    Oluwatowoju I; Abu E; Wild SH; Byrne CD
    Diabet Med; 2010 Mar; 27(3):354-9. PubMed ID: 20536500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of glycaemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication.
    Maahs DM; Ogden LG; Dabelea D; Snell-Bergeon JK; Daniels SR; Hamman RF; Rewers M
    Diabetologia; 2010 Dec; 53(12):2518-25. PubMed ID: 20820753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.
    Home PD; Pocock SJ; Beck-Nielsen H; Curtis PS; Gomis R; Hanefeld M; Jones NP; Komajda M; McMurray JJ;
    Lancet; 2009 Jun; 373(9681):2125-35. PubMed ID: 19501900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction.
    Hadjadj S; Coisne D; Mauco G; Ragot S; Duengler F; Sosner P; Torremocha F; Herpin D; Marechaud R
    Diabet Med; 2004 Apr; 21(4):305-10. PubMed ID: 15049930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).
    Prince CT; Becker DJ; Costacou T; Miller RG; Orchard TJ
    Diabetologia; 2007 Nov; 50(11):2280-8. PubMed ID: 17768606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.